Largest Swedish (OMX) Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Mar 21, 2025

Discover large cap Swedish Pharmaceuticals & Biotech companies that are on the OMX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

106 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
SOBI
Swedish Orphan Biovitrum
SEK 290.40-0.5%7.9%SEK 99.7bSEK 368.42PE25.7xE17.2%n/a
CAMX
Camurus
SEK 618.502.1%21.2%SEK 36.3bSEK 758.50PE84.7xE53.4%n/a
VITR
Vitrolife
SEK 170.30-4.8%-12.8%SEK 23.1bSEK 265.20PE44.9xE17.9%0.6%
BONEX
Bonesupport Holding
SEK 331.80-2.7%50.0%SEK 21.9bSEK 445.33PE163.4xE50.2%n/a
BIOA B
BioArctic
SEK 210.00-0.5%-1.7%SEK 18.6bSEK 333.60PS72.1xE38.9%0%
ALIF B
AddLife
SEK 148.30-0.8%36.6%SEK 18.1bSEK 184.00PE71.7xE30.2%0.5%
BIOG B
BioGaia
SEK 114.90-0.4%-11.6%SEK 11.6bSEK 160.00PE33.1xE15.0%6.0%
BIOT
Biotage
SEK 103.30-3.4%-40.5%SEK 8.3bSEK 155.00PE29.1xE20.4%1.6%
SECARE
Swedencare
SEK 38.00-2.6%-43.2%SEK 6.0bSEK 57.33PE61xE36.7%0.7%
MCAP
MedCap
SEK 362.00-3.1%-3.1%SEK 5.4bSEK 535.00PE26.1xS12.9%n/a
FLERIE
Flerie
SEK 45.002.0%n/aSEK 3.5bSEK 56.00PS1301.1xn/an/a
BICO
BICO Group
SEK 38.42-4.6%-2.3%SEK 2.7bSEK 64.67PS1.4xE54.5%n/a
BINV
BioInvent International
SEK 31.654.6%91.6%SEK 2.1bSEK 80.00PS46.6xE75.1%n/a
DVYSR
Devyser Diagnostics
SEK 110.002.8%10.0%SEK 1.8bSEK 164.37PS8.4xE94.7%n/a
VICO
Vicore Pharma Holding
SEK 7.653.9%-50.3%SEK 1.8bSEK 34.03PS16.4xE42.9%n/a
HNSA
Hansa Biopharma
SEK 23.607.3%-18.6%SEK 1.6bSEK 85.25PS9.3xE40.8%n/a
CRNO B
Cereno Scientific
SEK 5.253.1%19.3%SEK 1.5bn/aPS18.3xE10.0%n/a
GENO
Genovis AB (publ.)
SEK 21.25-2.5%-37.1%SEK 1.4bSEK 39.00PE42.3xE19.2%n/a
EGTX
Egetis Therapeutics
SEK 3.69-10.4%-45.2%SEK 1.3bSEK 11.40PS28.7xE107.6%n/a
ENZY
Enzymatica
SEK 4.8431.5%53.2%SEK 1.2bn/aPS25.8xn/an/a
XSPRAY
Xspray Pharma
SEK 29.15-2.7%-32.2%SEK 1.1bSEK 55.50PB1.7xE104.9%n/a
DMYD B
Diamyd Medical
SEK 8.381.2%-23.5%SEK 872.3mn/aPS7208.8xE-10.9%n/a
SYNACT
SynAct Pharma
SEK 15.33-7.1%121.2%SEK 751.3mSEK 16.20PB3.5xE59.9%n/a
HAMLET B
Hamlet BioPharma
SEK 4.05-3.6%108.8%SEK 719.6mn/aPB10.3xn/an/a
Page 1 of 5